Panel pressures FDA for final sunscreen monograph
This article was originally published in The Rose Sheet
A panel organized by the Citizens for Sun Protection calls for FDA to finalize the long-awaited sunscreen monograph, require sunscreens to provide both UVA and UVB protection and transparent labeling, and approve photostable, broad-spectrum sunscreen ingredients that defend against UVA and UVB rays, before another summer passes, according to Nov. 20 release. FDA issued in August 2007 a proposed rule to amend the OTC Sunscreen Drug Product Monograph by adding a UVA label standard. The rule is stalled in part because the industry views some labeling requirements as unduly burdensome (1"The Rose Sheet" Jan. 14, 2008, p. 3)
You may also be interested in...
Sunscreen labeling that claims the product "helps prevent" premature skin aging, cancer and other damage does not suggest that sunscreen alone protects against these conditions, but in fact informs consumers that "complementary measures" are needed for adequate protection, trade groups say
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.